ALDX
#3980
Aldeyra Therapeutics, Inc. - Common Stock
1.4 8 USD
-0.01%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-0.67%
Variación mensual
-4.52%
Variación en los últimos 6 meses
-72.59%
Cambio anual
-74.57%
Cierres anteriores
1.4 9
Open
1.4 8
Mínimo
1.4 8
Máximo
1.4 8
Volumen
16
Financials
- Market Capitalization 89.28 M
- Employee 6
- Founded 2004
- CEO Todd C. Brady M.D., Ph.D.
- Website www.aldeyra.com
- Headquarter Delaware, United States
- FIGI BBG0029H8ZF6
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-5.61
Relación precio/flujo de caja
—
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3977 |  ACRV Acrivon Therapeutics, Inc. - Common Stock | 2.09 USD | +1.46% | -5.43% | +37.50% | +59.54% | 89.56 M USD | ||
| 3979 |  ATRA Atara Biotherapeutics, Inc. - Common Stock | 8.90 USD | -3.26% | -7.00% | +5.70% | -39.66% | 89.34 M USD | ||
| 3981 |  RLYB Rallybio Corporation - Common Stock | 16.79 USD | -0.12% | -0.12% | +5.20% | +3128.85% | 89.16 M USD | ||
| 3984 |  ICCC ImmuCell Corporation - Common Stock | 9.79 USD | -1.51% | -0.81% | -13.59% | +55.64% | 88.91 M USD |